Liquid nitrogen-based Deep Frozen Solution will become part of a new healthcare services business
Having demo’d the technology at recent IQPC and other cold chain meetings, FedEx Corp. (Memphis) is now officially rolling out the technology, in partnership with CryoPort (San Diego), developer of the CryoPort Express Shipper. The service comprises CryoPort’s thermos bottle, with a capacity of 304 cu. in., and FedEx’s delivery and pickup services worldwide. In practice, all that a shipper need do is order one of the containers, which come prefilled with liquid nitrogen (and can sustain a temperature of -150 °C for up to 10 days), and fill out a destination form. FedEx brings the container, picks it up when ready and delivers it throughout its worldwide network, and handles returns and reuse of the container. FedEx’s Priority Alert service can be used to complete the delivery, providing express shipment as well as visibility during the shipment transit.
“This is an economical alternative to having the in-house capacity to stock and equip one’s own containers, charge them with coolant, and take care of delivery and return,” says Carl Asmus, VP of international market development at FedEx. He notes that liquid nitrogen is categorized as a non-hazardous substance, in contrast to the typically used refrigerant, dry ice.
Word is also trickling out about FedEx’s revamping of its life sciences service, which are going to be branded as FedEx HealthCare Solutions, and will include storage and fulfillment in addition to its range of dedicated air and ground-transport resources. According to Asmus, the unit will have a dedicated sales and service organization, providing one-stop access to the transportation services.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.